HER 2 LOW-EXPRESSING BREAST CANCER
Clinical trials for HER 2 LOW-EXPRESSING BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HER 2 LOW-EXPRESSING BREAST CANCER trials appear
Sign up with your email to follow new studies for HER 2 LOW-EXPRESSING BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo strategy aims to outsmart advanced breast cancer
Disease control Not yet recruitingThis study is testing if alternating between two newer, targeted cancer drugs can help patients with advanced triple-negative breast cancer live longer than using just one of the drugs. It will involve about 260 adults whose cancer has spread or cannot be removed by surgery. The …
Matched conditions: HER 2 LOW-EXPRESSING BREAST CANCER
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New scan could spot failing cancer drugs months earlier
Diagnosis Not yet recruitingThis study aims to determine if PET scans can identify ineffective cancer treatment earlier than standard CT scans. Researchers will compare PET scans against CT scans in 262 patients with metastatic breast cancer receiving T-DXd therapy. The goal is to help patients avoid contin…
Matched conditions: HER 2 LOW-EXPRESSING BREAST CANCER
Phase: NA • Sponsor: Centre Paul Strauss • Aim: Diagnosis
Last updated Mar 17, 2026 12:55 UTC
-
New scan aims to sharpen view of Hard-to-Spot tumors
Knowledge-focused Not yet recruitingThis study is testing whether a new radioactive tracer used in PET scans can help doctors better see and identify tumors in patients receiving standard HER2-targeted cancer treatments. Researchers will give the tracer to 30 adults with advanced HER2-positive cancers and use PET s…
Matched conditions: HER 2 LOW-EXPRESSING BREAST CANCER
Phase: EARLY_PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Knowledge-focused
Last updated Apr 04, 2026 02:20 UTC